XML 64 R43.htm IDEA: XBRL DOCUMENT v3.3.1.900
Goodwill and Other Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Carrying Amount of Goodwill
 
Balance as of December 31, 2015
Goodwill
Adjustments
and
Acquisitions
Balance as of December 31, 2014
Goodwill
Adjustments
and
Acquisitions
Balance as of December 31, 2013
Agriculture
$
336

$
18

$
318

$
(12
)
$
330

Electronics & Communications
149


149


149

Industrial Biosciences
839

(8
)
847

(51
)
898

Nutrition & Health
2,092

(101
)
2,193

(122
)
2,315

Performance Materials
383

8

375


375

Safety & Protection
449

(1
)
450

2

448

Total
$
4,248

$
(84
)
$
4,332

$
(183
)
$
4,515

Schedule of Other Intangible Assets
 
December 31, 2015
December 31, 2014
 
Gross
Accumulated
Amortization
Net
Gross
Accumulated
Amortization
Net
Intangible assets subject to amortization
     (Definite-lived)
 
 
 
 
 
 
Customer lists
$
1,621

$
(529
)
$
1,092

$
1,699

$
(465
)
$
1,234

Patents
454

(220
)
234

474

(184
)
290

Purchased and licensed technology
1,173

(649
)
524

1,783

(1,069
)
714

Trademarks
26

(13
)
13

26

(12
)
14

Other1
180

(72
)
108

202

(84
)
118

 
3,454

(1,483
)
1,971

4,184

(1,814
)
2,370

Intangible assets not subject to amortization
     (Indefinite-lived)
 
 
 
 
 
 
In-process research and development
72


72

29


29

Microbial cell factories2
306


306

306


306

Pioneer germplasm3
1,048


1,048

1,064


1,064

Trademarks/tradenames
747


747

800


800

 
2,173


2,173

2,199


2,199

Total
$
5,627

$
(1,483
)
$
4,144

$
6,383

$
(1,814
)
$
4,569


1. 
Primarily consists of sales and grower networks, marketing and manufacturing alliances and noncompetition agreements.
2. 
Microbial cell factories, derived from natural microbes, are used to sustainably produce enzymes, peptides and chemicals using natural metabolic processes. The company recognized the microbial cell factories as an intangible asset upon the acquisition of Danisco. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.
3. 
Pioneer germplasm is the pool of genetic source material and body of knowledge gained from the development and delivery stage of plant breeding. The company recognized germplasm as an intangible asset upon the acquisition of Pioneer. This intangible asset is expected to contribute to cash flows beyond the foreseeable future and there are no legal, regulatory, contractual, or other factors which limit its useful life.